← Eichor
Condition: Human Immunodeficiency Virus Hiv 1 Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Human Immunodeficiency Virus Hiv 1 Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Phase 4 · 10 location(s) · CAN Community Health · NCT07476339Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
Phase N/A · 7 location(s) · Pomeranian Medical University Szczecin · NCT07370649Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal o
NA · 5 location(s) · Centre Hospitalier Régional d'Orléans · NCT06834113The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
Phase 1 · 1 location(s) · ViiV Healthcare · NCT07525544Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Imm
Phase 1/Phase 2 · 1 location(s) · Jiangsu Aidea Pharmaceutical Group Co., Ltd. · NCT07711223Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05419024Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-0
Phase 2 · 24 location(s) · Merck Sharp & Dohme LLC · NCT04375800First Time in Human Study of Long Acting VH4524184 Formulations
Phase 1 · 3 location(s) · ViiV Healthcare · NCT06310551A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · 55 location(s) · Merck Sharp & Dohme LLC · NCT07266831Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
Phase 1 · 1 location(s) · ViiV Healthcare · NCT07636928A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
Phase 1 · 2 location(s) · ViiV Healthcare · NCT06724640A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · 30 location(s) · Merck Sharp & Dohme LLC · NCT07071623
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.